×
切換帳號
FAQ
新手指南
FAQ常見問題
學術會議
影音網
登入
×
全站搜尋
搜尋
台灣泌尿科醫學會E-School
登入
FAQ
新手指南
FAQ常見問題
學術會議
影音網
到官網
Home
到官網
Home
知識庫
目錄總覽
文件總覽
最新討論
目錄 / 資料夾
學術活動與演講
年會
2025半年會
摘要
2024年會
摘要
2024半年會
摘要
2023年會
摘要
2023半年會
摘要
2022年會
摘要
2021年會
摘要
2021半年會
摘要
2020年會
摘要
2020半年會
摘要
2019年會
摘要
2019半年會
摘要
2018年會
摘要
2018半年會
摘要
2017年會
摘要
2017半年會
摘要
2016年會
摘要
2016半年會
摘要
2015年會
摘要
新手指南與FAQ
知識庫
最新上傳
最新上傳
(
熱門
)
最新上傳
(
熱門
)
MP036: Initial experience of robotic assisted laparoscopic segmental ureterectomy with ureteroureterostomy for urothelial carcinoma of ureter
2017-06-01
MP035: Single port laparoscopic excision of an urachal cyst: Case report
2017-06-01
MP034: Retzius-sparing laparoscopic radical prostatectomy: A reversed evolution from robotic-assisted radical prostatectomy
2017-06-01
MP032: Immediately continent control of Retzius-sparing rarp- initial experience of 50 cases
2017-06-01
MP033: Post-operative complications after robot-assisted urological surgeries in a tertiary referral center as CMUH
2017-06-01
MP031: Application of a single camera stereoscopic endoscope in urology surgery: A cases study on surgeon
2017-06-01
MP030: Androgen deprivation therapy duration is associated with abiraterone acetate efficacy in metastatic castration resistance prostate cancer
2017-06-01
MP029: Positive predictive value of multiparametric magnetic resonance imaging in prostate cancer detection: the experience of Tungs’ Taichung Metroharbor Hospital
2017-06-01
MP028: High-intensity focused ultrasound (HIFU) therapy for localized prostate cancer : Cathy General Hospital experience
2017-06-01
MP027: Efficacy and safety of enzalutamide (ENZ) vs placebo (PL) in chemotherapy- naïve patients (pts) with progressive metastatic castration-resistant prostate cancer (mCRPC): Taiwan subgroup analysis of an Asian multiregional study
2017-06-01
MP026: The impact of different treatment modality in global quality of life among patients of prostate cancer
2017-06-01
MP024: Prognosis of prostate cancer with initial PSA at diagnosis beyond 1000 ng/ml
2017-06-01
MP025: Urodynamic changes in patients with prostate cancer who have undergone robotic-assisted radical prostatectomy: a comparison with laparoscopic radical prostatectomy
2017-06-01
MP023: Outcome of patients with metastatic castration-resistant prostate cancer after progressive disease of abiraterone acetate
2017-06-01
MP022: The value of prostate health index to predict magnetic resonance imaging lesions during active surveillance: A prospective cohort in Taiwan
2017-06-01
MP021: Prostate health index (PHI) improve prostate cancer detection at initial biopsy in Taiwanese men with PSA 4-10ng/ml
2017-06-01
MP020: Dynamic changes of quality of life in bladder cancer survivors with and without radical cystectomy
2017-06-01
MP019: Cisplatin induces protective autophagy through activation of BECN1 in human bladder cancer cells
2017-06-01
MP015: Comparison of the efficacy of adjuvant MEC (methotrexate, epirubicin and cisplatin) and GC (gemcitabine and cisplatin) in advanced upper tract urothelial carcinoma
2017-06-01
MP017: Predictive markers for the prognosis of muscle invasive bladder cancer treated with neoadjuvant chemotherapy
2017-06-01
MP018: The implication of macrophage polarization and urinary tract infection in development and progression of urothelial carcinoma
2017-06-01
MP016: Comparison of long-term outcome of patients regarding the efficacy of second-look transurethral resection of bladder tumor for T1 bladder cancer: A five-year experience in a single center
2017-06-01
MP014: A novel quinazoline derivative, MJ-56, exhibits phototoxicity toward human bladder cancer cells
2017-06-01
MP012: Quercetin induces protective autophagy in human bladder cancer cells
2017-06-01
<
91
92
93
94
95
96
97
98
99
100
>
/ 127